AptaBio Therapeutics Inc. (293780.KQ) KOE

8,190.00

-110(-1.33%)

Updated at September 09 11:21AM

Currency In KRW

Valuation

Market Cap146.92B
Enterprise Value128.9B
P/E Ratio-8.74
PEG Ratio-0.72
Price/Sales Ratio70.83
Price/Book Ratio4.26
Enterprise/Revenue67.3
Enterprise/EBITDA-15.64

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-8.1
Operating Margin-6.2

Management Effectiveness

Return On Assets-0.35
Return On Equity-0.49

Income Statement

Revenue3.36B
Revenue/Share115.64
Gross Profit286.62M
EBITDA-23.87B
Net Income-29.38B
Diluted EPS-1,273.72

Balance Sheet

Total Cash24.91B
Total Cash/Share926.5
Total Debt7.97B
Total Debt/Equity0.15
Current Ratio1.79
Book Value Per Share1,924.5

Price History

52-Week Change-2.03
52-Week High11,960
52-Week Low5,750
Moving Average 50 Days8,459.4
Moving Average 200 Days7,523.3

Statistics

Average Volume370,209
Shares Outstanding26.88M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor2:1
Last Split DateAugust 24, 2021